Select Publications
Preprints
, 2019, Anti-Thymocyte Globulin for Patients Undergoing Hematopoietic Cell Transplantation from Unrelated Donors: A Randomized, Controlled, Open-Label, Phase 3, Multicentre Trial from Cell Therapy Transplant Canada, http://dx.doi.org/10.2139/ssrn.3429920
, Real-world outcomes of acute lymphoblastic leukaemia in AYA and older adults: impact of molecular MRD on risk-adapted therapy and allogeneic transplantation, http://dx.doi.org/10.21203/rs.3.rs-10880284/v1
, Romosozumab Safely Restores Bone Mass in Multiple Myeloma via Osteoblast Reprogramming: A Phase IIa Study, http://dx.doi.org/10.64898/2026.07.02.26357196